Received: 4 June 2021
Accepted: 4 August 2021
First Online: 12 August 2021
: The purpose and experimental procedures of the study were explained to all alive patients and legally authorized representative of one deceased patient, who gave informed written consent prior to the study. All patients or their authorized representative explicitly provided permission for genotyping as well as for collection of relevant clinical data. The study was conducted according to the standards of the Declaration of Helsinki and was approved by The Ethics Committees of People’s Hospital of Xinjiang Uygur Autonomous Region (approval number: 2014063).
: Not applicable.
: The authors declare that they have no competing interests.